Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when OSCR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOscar Health reaffirms 2026 guidance, announces Board leadership changes
Filed April 21, 2026 · Period ending April 21, 2026 · ~1 min read
Key Changes
-
medium
Oscar Health reaffirmed its full year 2026 financial guidance ahead of conference participation, signaling management confidence in meeting previously announced targets for the year.
Item 7.01 verify on EDGAR → -
medium
The company announced upcoming changes to Board of Directors leadership, though specific details are contained in a separate press release not included in the filing body.
Item 7.01 verify on EDGAR → -
low
First quarter 2026 earnings will be released before market open on May 6, 2026, followed by a conference call at 8:00 AM ET to discuss results.
Item 7.01 verify on EDGAR →
Summary
Oscar Health filed an 8-K to reaffirm its full year 2026 financial guidance ahead of its appearance at the Medicarians 2026 conference. The reaffirmation suggests management remains confident the health insurance company is on track to meet its previously disclosed financial targets, providing continuity for investors. The company also announced changes to its Board leadership structure, though the specific nature of these governance changes requires reviewing the attached press release.
For retail investors, the guidance reaffirmation is a positive signal that Oscar's business trajectory remains stable through the first quarter. The Board changes merit attention depending on their scope—whether they involve the Chairman, committee leadership, or other key governance roles. Watch for the Q1 earnings release on May 6 to see if the company's actual performance supports this reaffirmed guidance and whether management provides any additional color on the Board transition during the earnings call.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Oscar Health, Inc. (the “Company”), in advance of its upcoming participation in the Medicarians 2026 conference on April 21, 2026, is reaffirming the full year 2026 guidance that it provided in its financial results press release for the fourth quarter and full year 2025 dated February 10, 2026.
The company is reaffirming its previously announced full year 2026 financial guidance ahead of a conference appearance. This signals management confidence that the company remains on track to meet its financial targets for the year. The reaffirmation provides continuity and reduces uncertainty for investors.
Added in current filing · verify on EDGAR →
On April 21, 2026, the Company issued a press release announcing upcoming changes to its Board leadership.
The company announced changes to its Board of Directors leadership structure. While the 8-K references a separate press release (Exhibit 99.1) for details, this signals governance changes at the board level. The nature and impact of these changes would require reviewing the referenced press release.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
As previously announced, the Company expects to release first quarter 2026 financial results before the market opens on Wednesday, May 6, 2026, and host a conference call to review results beginning at 8:00 AM (ET).
The company confirms it will report first quarter 2026 results on May 6, 2026, before market open, followed by a conference call at 8:00 AM ET. This provides investors with the specific date to expect quarterly financial performance disclosure.
Event · Item 9.01 — Financial Statements and Exhibits
Oscar Health filed an 8-K attaching a press release dated April 21, 2026; no material event details disclosed in the filing body.
Added in current filing · view on EDGAR →
99.1 Press Release, dated April 21, 2026
The 8-K references an attached press release dated April 21, 2026, but the filing body does not disclose the content or subject matter of that release. Without the exhibit text, the nature and materiality of the disclosed event cannot be determined from this filing alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify